The Latest Cardiac and Vascular News
SAN DIEGO, March 10, 2020 /PRNewswire/ — Today, AnaBios announced a Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) to study adult human primary cardiomyocytes as a reference for cellular properties and drug-induced effects on cardiac function. Under the RCA, the FDA Center for Drug Evaluation and Research (CDER) […]
First 3-year-old patient successfully implanted and discharged from hospital in Berlin BAAR, Switzerland and BERLIN, March 10, 2020 /PRNewswire/ — CARAG AG, a Swiss privately held medical device development company, announced today the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, metal-free framework, as part of a new international post-market registry. The […]
ST. LOUIS, March 10, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended December 31, 2019. “The past year was transformative for Stereotaxis with significant progress financially, commercially and […]
One of the nation’s leading cardiologists and Medical Director of UHealth Cardiology to advise on clinical practices Westport, CT, March 10, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity […]
Robust CGuard™ EPS year-over-year revenue growth of 31% Management to host investor conference call today, March 10, at 8:30am ET TEL AVIV, Israel, March 10, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of […]
Biomedical Company Hires Denver Agency for Strategic Guidance and Marketing Support DENVER–(BUSINESS WIRE)–Catalyst, a Denver marketing agency, today announced that they were selected by CryoLife, a biomedical company, for marketing services. The marketing services include design, content development and sales enablement tools creation. Headquartered in suburban Atlanta, Georgia, CryoLife is one of the […]
SEATTLE–(BUSINESS WIRE)–NanoSurface Biomedical announced today that it has executed an exclusive IP license agreement related to innovative heart-on-chip technology developed by researchers at the University of Washington (UW). An experimental system built from the same heart-on-chip technology was launched into space on Friday, March 6, 2020 at 11:50 PM EST aboard […]
TOKYO–(BUSINESS WIRE)–Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today announced it has entered into agreement with ITOCHU CHEMICAL FRONTIER Corporation (headquartered in Minato-ku, Tokyo; President & CEO Tsutomu Miyazaki, hereinafter ICF) to form a financial business partnership. In accordance […]
Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a company dedicated to improving the lives of people with heart failure and developer of the innovative CCM™ therapy delivered by the Optimizer® Smart System, today announced the appointment of Ishu Rao, […]
46% Q4 revenue growth; 51% full year growth BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the fourth quarter and 12 months ended December 31, 2019. “We’re pleased to close out another year of compelling […]
